FutureTech II Acquisition Corp.

Formerly Future Tech II Acquisition Corp.

• 4 December 2024Exhibit 99.1 FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress TowardsListing & compliance
• 20 September 2024EXHIBIT 99.1 Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human HealthDeal announced
• 17 May 2023Exhibit 99.1 FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business CombinationExtension
• 21 February 2023Exhibit 99.1 FutureTech II Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business CombinationCombination closed
• 8 April 2022Exhibit 99.1 FutureTech II Acquisition Corp. Announces** **the Separate Trading of its Class A Common Stock and WarrantsSeparate trading
• 24 February 2022Exhibit 99.2 FutureTech II Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment OptionIPO closing

The figures above are what the filings state. These are what SPAC Watch derives from them, and they are in the app.

• Risk classification and the disclosure it is drawn from
• Warrant fair value, exercise terms and redemption triggers
• Redemption history — every vote, rate and share count
• Trust runway, working capital and sponsor loans
• Institutional holders and their reported positions
• Directors, officers and the sponsor’s prior SPACs